Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients

In this study, we analysed the expression level of sera circulating miRNA-5196 in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients before and after tumor necrosis factor (TNF)-α therapy as biomarkers predicting positive treatment outcome. We enrolled 10 RA patients, 13 AS patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciechomska, Marzena, Bonek, Krzysztof, Merdas, Michal, Zarecki, Patryk, Swierkot, Jerzy, Gluszko, Piotr, Bogunia-Kubik, Katarzyna, Maslinski, Wlodzimierz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154007/
https://www.ncbi.nlm.nih.gov/pubmed/29744553
http://dx.doi.org/10.1007/s00005-018-0513-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154007/
https://www.ncbi.nlm.nih.gov/pubmed/29744553
http://dx.doi.org/10.1007/s00005-018-0513-y

Ejemplares similares